PIK3CA and inflammatory breast carcinoma: In our study, a PIK3CA mutation was found at a rate of 25.5% on initial biopsy, corroborating recently published data about IBC, with a rate of 29.5% among 156 patients and a rate of 28% among 53 patients, reported by Liang et al. and Ross et al., respectively35,36.